Refreshing results…
Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase
UploadEffectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19
UploadComparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic
Download from doi.orgMissing publications? Search for publications with a matching author name.